Status:
COMPLETED
Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis
Lead Sponsor:
Stallergenes Greer
Collaborating Sponsors:
Venn Life Sciences
Conditions:
Allergy
Eligibility:
All Genders
5-9 years
Brief Summary
Safety and tolerability of ORALAIR in children 5 to 9 years of age during the first 30 days of treatment.
Detailed Description
The purpose of this study is to further describe the safety and tolerability of ORALAIR tablets in children 5 to 9 years of age with grass-pollen-induced allergic rhinitis with or without conjunctivit...
Eligibility Criteria
Inclusion
- Allergen immunotherapy naive male or female outpatients aged 5 to 9 years (inclusive) prescribed ORALAIR.
Exclusion
- Patients already participating in a clinical trial.
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 3 2017
Estimated Enrollment :
307 Patients enrolled
Trial Details
Trial ID
NCT02295969
Start Date
December 1 2014
End Date
July 3 2017
Last Update
July 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Augsburg, Klinik für Kinder und Jugendliche
Augsburg, Bavaria, Germany, 86156